Aptose Biosciences Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aptose Biosciences Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Aptose Biosciences Inc. Return On Equity for the quarter ending June 30, 2024 was -5.68K %, a 3613% decline year-over-year.
  • Aptose Biosciences Inc. annual Return On Equity for 2023 was -459 %, a 463% decline from 2022.
  • Aptose Biosciences Inc. annual Return On Equity for 2022 was -81.5 %, a 15.5% decline from 2021.
  • Aptose Biosciences Inc. annual Return On Equity for 2021 was -70.6 %, a 32.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -459 -377 -463% Jan 1, 2023 Dec 31, 2023
2022 -81.5 -10.9 -15.5% Jan 1, 2022 Dec 31, 2022
2021 -70.6 -17.3 -32.4% Jan 1, 2021 Dec 31, 2021
2020 -53.3 +8.33 +13.5% Jan 1, 2020 Dec 31, 2020
2019 -61.6 +133 +68.3% Jan 1, 2019 Dec 31, 2019
2018 -195 -72.3 -59.2% Jan 1, 2018 Dec 31, 2018
2017 -122 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.